Today on Pharmaceutical Processing
Phlow lands $354m government contract for COVID-19 medications
ACG receives Clean Label Project certification for capsules
Regulatory See More >
AbbVie gains U.S. nod for $63B Allergan takeover
Pharmaceutical giant AbbVie (NYSE:ABBV) has won U.S. antitrust approval for its purchase of Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie’s blockbuster drug, Humira. North Chicago-based AbbVie announced the deal in June 2019, but ran up against U.S. Federal Trade Commission…
Facility See More >
The Rapid Rise of Modular Construction—Are Standardized Facilities Next?
In recent years, the discussion for flexible facility needs became widespread. The motivations for such flexible facility needs are manifold, for example, the requirement to rapidly deploy additional manufacturing capacities or scalability without interrupting existing processes. In addition, the transformation of the treatment or patient base to more personalized medicines necessitates the need to rethink…
Supply Chain See More >
Mass-producing a COVID-19 vaccine is going to be hard
Creating a safe and effective COVID-19 vaccine is just the first step. Recent media reports suggest that making it will also be a major challenge. There are presently a number of vaccine candidates around the world that are showing promise and entering the clinical studies phase — a speed of development usually unheard of in…
Recalls See More >
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs…
